Fiera Capital Corp Has $49.46 Million Stake in Danaher Co. (NYSE:DHR)

Fiera Capital Corp lessened its holdings in Danaher Co. (NYSE:DHR - Free Report) by 8.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 177,898 shares of the conglomerate's stock after selling 16,200 shares during the period. Fiera Capital Corp's holdings in Danaher were worth $49,459,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. CarsonAllaria Wealth Management Ltd. bought a new position in Danaher in the 2nd quarter valued at $25,000. nVerses Capital LLC purchased a new stake in shares of Danaher during the second quarter worth about $25,000. MFA Wealth Advisors LLC purchased a new position in shares of Danaher during the second quarter valued at approximately $51,000. Financial Connections Group Inc. purchased a new stake in shares of Danaher in the 2nd quarter worth about $51,000. Finally, Western Pacific Wealth Management LP bought a new position in shares of Danaher in the 1st quarter worth approximately $55,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Stock Down 0.3 %

Shares of NYSE:DHR traded down $0.69 during midday trading on Friday, reaching $245.41. The company had a trading volume of 2,941,104 shares, compared to its average volume of 2,744,089. Danaher Co. has a one year low of $192.35 and a one year high of $281.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The stock has a market capitalization of $177.25 billion, a P/E ratio of 46.83, a PEG ratio of 4.54 and a beta of 0.85. The stock's fifty day moving average price is $264.89 and its 200-day moving average price is $260.71.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the previous year, the business earned $2.02 EPS. The business's quarterly revenue was up 3.1% on a year-over-year basis. Equities research analysts expect that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. The ex-dividend date was Friday, September 27th. Danaher's dividend payout ratio (DPR) is presently 20.61%.

Insiders Place Their Bets

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares of the company's stock, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 10.90% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Wolfe Research raised Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 target price on the stock in a report on Thursday, October 31st. Wells Fargo & Company initiated coverage on Danaher in a research note on Tuesday, August 27th. They issued an "equal weight" rating and a $280.00 price objective for the company. The Goldman Sachs Group upped their target price on shares of Danaher from $225.00 to $250.00 and gave the stock a "neutral" rating in a report on Wednesday, July 24th. Bank of America lifted their price objective on shares of Danaher from $270.00 to $275.00 and gave the company a "neutral" rating in a research report on Wednesday, July 24th. Finally, Leerink Partners upped their price objective on Danaher from $275.00 to $280.00 and gave the stock an "outperform" rating in a report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, Danaher has an average rating of "Moderate Buy" and an average target price of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.